This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Reeder has been faculty at UW-Madison since 2005 and previously served as director of the clinicalmagneticresonanceimaging fellowship, chief of MRI, chief of sectional cardiovascular imaging, and senior vice chair of research. Reeder's term becomes effective in early 2024, according to UW.
Reeder has been faculty at UW-Madison since 2005 and previously served as director of the clinicalmagneticresonanceimaging fellowship, chief of MRI, chief of sectional cardiovascular imaging, and senior vice chair of research. Reeder's term becomes effective in early 2024, according to UW.
milla1cf Fri, 11/03/2023 - 12:22 November 3, 2023 — Guerbet , a global leader in medical imaging with more than 30 years of experience in MRI, announced today its schedule of activities at the 2023 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting from November 26-30 in Chicago, IL.
milla1cf Wed, 12/20/2023 - 15:41 December 20, 2023 — Terran Biosciences, Inc. , We believe this technology could become very important in the clinical workflow of patients with neurological and psychiatric disorders.” It’s great to see neuromelanin MRI become more accessible in clinical settings,” said Dr. Horga. “We
milla1cf Fri, 06/02/2023 - 20:28 June 2, 2023 — Philips has entered into a collaboration with medical imaging company Polarean to advance the field of hyperpolarized Xenon MRI for patients with respiratory illness.
christine.book Tue, 06/20/2023 - 14:03 June 20, 2023 — Ascelia Pharma presented data from its Orviglance Hepatic Impairment study during the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) 2023 annual meeting held June 14-16 in Valencia, Spain.
milla1cf Mon, 12/11/2023 - 14:23 December 11, 2023 — Bracco Imaging S.p.A. , 4 Thanks to its high relaxivity, large, multicenter, adequate and well controlled clinical studies have shown that Vueway provides similar diagnostic efficacy at half the dose of gadobutrol, a GBCA routinely used in clinical practice in the EU.
milla1cf Fri, 10/20/2023 - 18:29 October 20, 2023 — In certain cases, a new method can provide as much information from brain images taken with computed tomography (CT) as images captured with magneticresonanceimaging (MRI). For more information: [link] Friday, October 20, 2023 - 18:29
The companies are partnering to further enable the Polarean xenon 129 MRI platform to accelerate clinical and research use. These new products and services will be utilised to expand access to xenon 129 MRI as a lung imaging service and to investigate new indications and biomarkers in broader populations with unmet medical needs.
In a new review published in the KeAi journal Meta-Radiology , a team of researchers from the Chinese PLA General Hospital in China summarized the clinical trials of high-intensity FUS in the treatment of intracranial diseases. Therefore, further preclinical and clinical studies are required to explore these effects.
milla1cf Thu, 07/06/2023 - 22:19 July 7, 2023 — Bayer , a global leader in radiology, has initiated the Phase III clinical development program called QUANTI , aiming to evaluate the safety and efficacy of gadoquatrane, an investigational extracellular macrocyclic gadolinium-based contrast agent (GBCA) for use in magneticresonanceimaging ( MRI ).
LEADS participants receive a standard clinical evaluation and MagneticResonanceImaging ( MRI ) scanning as well as amyloid and tau PET scanning and fluid biomarker assessments on an annual basis. What Are the Clinical Implications? What Were Your Findings? Alzheimer’s Dement.
milla1cf Thu, 06/15/2023 - 00:06 June 14, 2023 — TGH Imaging has implemented the Philips Radiology Operations Command Center (ROCC) at several of its outpatient locations offering magneticresonanceimaging testing. For more information: www.tghimaging.com Thursday, June 15, 2023 - 00:06
milla1cf Tue, 06/13/2023 - 20:08 June 13, 2023 — Hyperfine, Inc. The ISMRM, a non-profit organization, has long promoted MR research and its translation into clinical practice, fostering dialogue among scientific and clinical professionals and driving the development and application of MR techniques.
John Nigro , Division Chief of Cardiac Surgery & Cardiac Transplant Services at Rady Children’s Hospital , Helen and Will Webster Foundation Chief of Cardiothoracic Surgery, Co-Director, Rady Children’s Heart Institute, and clinical professor of surgery at UC San Diego School of Medicine.
milla1cf Mon, 05/15/2023 - 11:00 May 15, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI , announced that based on the most recent scientific and clinical evidence, the ACR Committee on Drugs and Contrast Media has classified Elucirem ( gadopiclenol ) as a Group II agent.
He further reported, “Following considerable challenges during the SPARKLE study, we are very excited to complete the Orviglance clinical development with these strong results in Phase 3. Therefore, a new evaluation of the images with new readers was required.
With the advent of highly portable magneticresonanceimaging (pMRI), the scanner will now come to them. The project findings were presented and debated in a December 2023 public conference on Emerging Portable Technology for Neuroimaging Research in New Field Settings: Legal & Ethical Challenges.
The results also follow those of the PICTURE clinical trial published in Investigative Radiology in May, 2023, which found the non-inferior quality of morphologic assessment of lesions of the brain and spine with VUEWAY compared with Gadavist. mmol/kg versus a full dose of gadobutrol (0.1 mmol/kg). [i] mmol/kg gadobutrol (Gadavist).[ix]
milla1cf Thu, 04/06/2023 - 17:11 April 6, 2023 — The neonatology team at Bonn University Hospital ( UKB ) has conducted the world's first study of children receiving ECMO therapy using the mobile magneticresonanceimaging (MRI). For more information: [link] Thursday, April 6, 2023 - 17:11
milla1cf Thu, 07/27/2023 - 23:20 July 27, 2023 — Scientists have found a new use for copper in magneticresonanceimaging (MRI) contrast agent design, that could help to create better images which help doctors diagnose patients’ conditions more easily and safely.
milla1cf Mon, 06/26/2023 - 19:53 June 27, 2023 — Bayer announced that Ultravist (iopromide)-300, -370, its iodine-based contrast agent, has been approved by the U.S. CEM is easy to perform in everyday clinical practice and can be used in various clinical settings, such as when routine imaging produces inconclusive findings.
For patients with residual or recurrent grade 2 isocitrate dehydrogenase (IDH)-mutant gliomas, magneticresonanceimaging (MRI) revealed that daily dosing of vorasidenib, an inhibitor of mutant IDH1 and IDH2 enzymes, led to a median progression-free survival of 27.7 months in comparison to 11.1
Prostate MR quality At Weill Cornell Medical College in New York City, Heejong Kim, PhD; Daniel Margolis, MD; and colleagues have pointed out that the problem of high variability in MRI image quality hinders comparative research and multicenter clinical trials, which are especially important given the popularity of mpMRI.
milla1cf Wed, 07/12/2023 - 10:25 July 12, 2023 — Eyas Medical Imaging announced the first installation of the groundbreaking neonatal MagneticResonanceImaging (MRI) system, the Ascent 3T , within the neonatal intensive care unit (NICU) at Cincinnati Children’s.
He received the Frank Doyle medal (RCR), and ECPR Junior Grant in 2023 was selected for IRIYA at RSNA 2024. Marliza ODwyer is a radiology Specialist Registrar at St Jamess Hospital, Dublin, Ireland, with a clinical and research focus on Cardiothoracic and Interventional Radiology. Rodolico in Catania, Italy.
tim.hodson Tue, 08/01/2023 - 10:54 The healthcare industry faces many different types of obstacles in today’s challenging marketplace. Staff shortages , increased workloads and financial pressure are just some of the challenges facing hospitals and clinics.
3 Tesla (3T) magneticresonanceimaging whole-body scanner. This scanner features the industry’s strongest gradient system for a clinically released whole-body MR scanner, providing improved visibility of smaller structures in the body and faster image capture.
Today, it is essential in the fields of neuroscience and clinical medicine. In the Center for MagneticResonance Research at the U of M, the research team plans to use MRI techniques to create different types of images that are needed for various research purposes.
Key Points: While magneticresonanceimaging (MRI) adequately detects the size and presence of osteophytes (OPs) in the medial tibio-femoral compartment, it underestimates OPs in all other knee compartments of osteoarthritic patients. Clinical trials will often use MRI to assess and grade OPs in arthritic knees.
mtaschetta-millane Wed, 07/12/2023 - 07:00 They say good things come in small packages. Here you’ll find a highly skilled, compassionate staff along with comprehensive advanced imaging technologies that are raising the bar for patient care in their rural community. But most importantly, image quality is greatly improved.
Along with the new Revolution RT unveiling, GE HealthCare is also revealing an updated and artificial intelligence (AI)-enhanced version of its Intelligent Radiation Therapy (iRT) platform, which interfaces with the Spectronic magneticresonanceimaging (MRI) Planner. Last accessed February 2023. Available at: [link] .
Magneticresonanceimaging will help to evaluate ligamentous injury and provides a 94% predictive value for diagnosing Lisfranc injury [5]. Published 2023 Mar 1. It is useful when measuring M2-C1 distance and comparing the sides of the foot [8]. Chen C, Jiang J, Wang C, Zou J, Shi Z, Yang Y. J Foot Ankle Res.
tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image. Horowitz, et al, Medical Hypotheses , October 13, 2023.
milla1cf Tue, 08/08/2023 - 20:34 August 8, 2023 — Fresenius Kabi announced it has launched Gadobutrol Injection, a generic substitute for the contrast agent Gadavist, which is used in magneticresonanceimaging (MRI) procedures.
milla1cf Tue, 10/03/2023 - 12:04 October 3, 2023 — The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. professor of Imaging Physics , named to 2023 class of ASTRO Fellows Wendy Woodward, M.D.,
0000000000001232 Cerebral small vessel disease (CSVD) is one of the most common clinical conditions that a neuroimager will encounter. CSVD is associated with an increased risk of clinical ischemic and hemorrhagic stroke, silent infarcts, and cognitive decline and dementia. Continuum (Minneap Minn). 2023;29(2):501-518. doi:10.1212/CON.0000000000001232
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content